ArticleEBioMedicine2019
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.
Haiyun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it